Table 1.

Dynamics of individual HMO concentrations during the 3 to-12-month lactation period.

HMO	Milk group	Coefficient	q-value <0.1
2'FL	Se+/Le+	−0.167	0.051
3FL	Se+/Le+	0.204	0.087
6'SL	Se–/Le+	−0.960	0.002
6'SL	Se+/Le–	−0.888	0.059
6'SL	Se+/Le+	−1.049	<0.001
DFLNHa	Se+/Le+	−0.777	<0.001
LNDFH-I	Se+/Le+	−0.212	0.065
LNFP-I	Se+/Le+	−0.408	<0.001
LNFP-III	Se+/Le+	−0.203	<0.001
LNH	Se+/Le–	−0.571	0.003
LNH	Se+/Le+	−0.580	<0.001
Hex4HexNAc2	Se+/Le+	−0.693	<0.001
LNnDFH	Se+/Le+	0.370	0.036
LNnFP-V	Se–/Le+	−0.480	0.004
LNnFP-V	Se+/Le+	−0.470	<0.001
LNnT	Se+/Le+	−0.604	<0.001
LNT	Se+/Le+	−0.283	0.025
LSTc	Se–/Le+	−1.269	<0.001
LSTc	Se+/Le–	−1.352	0.059
LSTc	Se+/Le+	−1.263	<0.001
MFLNH-III	Se+/Le+	−0.836	<0.001

Only significant and adjusted-for-multiple-testing changes are reported in the table.

2′FL, 2′-O-Fucosyllactose; 3FL, 3-O-Fucosyllactose; 6′SL, 6′-O-Sialyllactose; DFLNHa, Difucosyllacto-N-hexaose a; LNDFH-I, Lacto-N-difucohexaose-I; LNFP-I,–III, Lacto-N-fucopentaose-I,-III; LNH, Lacto-N-hexaose; Hex, Hexose; HexNAc, N-acetylhexosamine; LNnDFH, Lacto-N-neodifucosylhexaose; LNnFP-V, Lacto-N-neofucopentaose-V; LNnT, Lacto-N-neotetraose; LNT, Lacto-N-tetraose; LSTc, Sialyllacto-N-tetraose c; MFLNH-III, Monofucosyllacto-N-hexaose-III„ Human Milk Oligosaccharide; q-value, level of confidence after correction for multiple HMO testing.